Crizalk 200mg Capsule: Effective Relief Solution

Uses:

• Treatment of Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC) that is locally advanced or metastatic.

Active substance:

• Crizotinib.

Therapeutic effects:

• Crizalk 200mg is a tyrosine kinase inhibitor that works by blocking the activity of the anaplastic lymphoma kinase (ALK) protein. It specifically targets the abnormal protein and blocks its activity, slowing down or stopping the growth and spread of cancer cells.

Dosage and administration:

• The recommended dose is one capsule of 250 mg taken orally twice daily.
• Swallow the capsules whole and do not crush, chew, dissolve, or open the capsules.
• Your physician will choose the dosage and administration frequency based on the medical condition because it differs for each person.

Safety advice:

• Do not take if you are allergic to Crizotinib or any other ingredients of this medicine.
• Inform your physician if you have had kidney, stomach, heart, or liver problems.
• Notify your doctor if you have reduced white blood cells, abnormal heart tracing after ECG, vision problems, or if you take other medications.
• Report your doctor immediately if you are planning to get pregnant or think you may be pregnant.
• Use effective birth control during the treatment because oral contraception is ineffective with this medicine and use it at least for 90 days even after completing the therapy with Crizalk 200mg capsule.
• It is advised to get suggestions about fertility concerns from your doctor.
• This medication is not recommended for adolescents and children under 18 years of age.
• Use a sunscreen or protective clothing to cover the skin to protect them against sunburn.

Interaction with other drugs:

• Inform your healthcare provider about all the medicines you take, including prescription medications, over-the-counter medications, recent vaccinations, nutritional and vitamin supplements, and herbal products.
• Certain medications such as Erythromycin, Diltiazem, Verapamil, and other medications may interact with Crizalk 200mg and reduce its effectiveness by causing undesirable side effects.

Storage:

• Store at room temperature (15-30˚C) in the original container.
• Keep this medicine out of the sight and reach of children.

Side effects:

• Serious: pain on the right of the stomach, partial or full loss of vision, lowered WBC, low heart rate, swelling of the lungs, breathlessness, cough with or without mucus.
• Common: sensitivity to sunlight, diarrhea, fever, constipation, nausea, increased liver enzymes, decreased appetite, tiredness (fatigue), dizziness, neuropathy (weakness, tingling, or numbness in the nerve), dysgeusia (taste disorder), hypophosphataemia (low levels of phosphate in the blood).

FAQs:

1. Does Crizalk 200mg cure cancer? Crizalk 200mg is not a cure for cancer, but it can help to slow down or stop the growth and spread of cancer cells, improving the overall survival and quality of life of patients with certain types of cancer.
2. What should I do if I miss a dose of Crizalk 200mg? If you miss a dose of Crizalk 200mg, you should take it as soon as you remember. However, if it is almost time for your next dose, skip the missed dose and continue with your regular dosing schedule.
3. What should I tell my doctor before taking Crizalk 200mg? Before taking Crizalk 200mg, you should tell your doctor if you have liver or kidney problems, a history of heart disease, or are pregnant or planning to become pregnant.
4. Why there are low levels of phosphate in the blood while taking Crizalk 200mg? The exact mechanism by which Crizalk 200mg causes hypophosphatemia (low level of phosphate) is not fully understood, but it is thought to be related to the inhibition of certain enzymes involved in phosphate transport and metabolism in the body.
5. Can Crizalk 200mg be used in combination with other cancer medications? Crizalk 200mg may be used in combination with the chemotherapy drugs Pemetrexed and Cisplatin in the first-line treatment of ALK-positive non-small cell lung cancer (NSCLC). It depends on the specific cancer diagnosis and treatment plan.

Fact box:

• Molecule name: Crizotinib.
• Therapeutic class: Antineoplastic drug.
• Pharmacological class: Tyrosine kinase inhibitors.
• Indication: Anaplastic lymphoma kinase (ALK) positive non-small cell lung cancer (NSCLC).

Tags: Crizalk, medication, capsule, 200mg, health, pharmacy, medical, drugs, healthcare, medicine